ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 100 filers reported holding ATOSSA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,687 | -54.6% | 21,300 | -22.3% | 0.00% | – |
| Q2 2023 | $34,524 | -21.7% | 27,400 | -54.9% | 0.00% | – |
| Q1 2023 | $44,074 | -9.0% | 60,800 | -33.6% | 0.00% | – |
| Q4 2022 | $48,411 | -45.0% | 91,600 | -13.1% | 0.00% | – |
| Q3 2022 | $88,000 | -36.7% | 105,400 | -17.2% | 0.00% | – |
| Q2 2022 | $139,000 | -83.7% | 127,300 | -81.3% | 0.00% | -100.0% |
| Q1 2022 | $852,000 | -66.7% | 681,600 | -57.3% | 0.00% | -66.7% |
| Q4 2021 | $2,557,000 | +790.9% | 1,597,930 | +1715.8% | 0.01% | +500.0% |
| Q3 2021 | $287,000 | +18.1% | 88,000 | +128.6% | 0.00% | 0.0% |
| Q2 2021 | $243,000 | +138.2% | 38,500 | -20.5% | 0.00% | – |
| Q1 2021 | $102,000 | +920.0% | 48,400 | +348.1% | 0.00% | – |
| Q4 2020 | $10,000 | -66.7% | 10,800 | -11.5% | 0.00% | – |
| Q3 2020 | $30,000 | – | 12,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 347,392 | $256 | 0.02% |
| XTX Topco Ltd | 167,427 | $123,310 | 0.02% |
| Laurion Capital Management LP | 2,225,800 | $1,639,302 | 0.01% |
| Virtu Financial LLC | 80,728 | $59 | 0.01% |
| Renaissance Technologies | 1,242,370 | $915 | 0.00% |
| LVM CAPITAL MANAGEMENT LTD/MI | 21,000 | $15 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 50,000 | $36,825 | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 133,591 | $98,390 | 0.00% |
| Caption Management, LLC | 75,000 | $55,238 | 0.00% |
| J. L. Bainbridge & Co., Inc. | 11,121 | $8,191 | 0.00% |